New York, Oct. 10, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Continuous Renal Replacement Therapy (CRRT) Industry" - https://www.reportlinker.com/p05798256/?utm_source=GNW
Online interactive peer-to-peer collaborative bespoke updates
Access to our digital archives and MarketGlass Research Platform
Complimentary updates for one year
- Global Continuous Renal Replacement Therapy (CRRT) Market to Reach $1.7 Billion by 2026
- Continuous renal replacement therapy (CRRT) is the most widely used therapy in critically ill patients as these hypotensive patients require slow removal of waste and water without causing hypotension. As renal replacement therapy for pediatric patients with Acute Kidney Injury (AKI) becomes more commonplace, CRRT gains traction as a suitable treatment modality for patients of any size and who are hemodynamically unstable. The growing prevalence of cardiovascular diseases is the underlying factor for acute kidney injury cases, which is expected to drive the demand for CRRT. Amid the COVID-19 crisis, the global market for Continuous Renal Replacement Therapy (CRRT) estimated at US$1.4 Billion in the year 2022, is projected to reach a revised size of US$1.7 Billion by 2026, registering a compounded annual growth rate (CAGR) of 5.8% over the analysis period. The United States represents the largest regional market for Continuous Renal Replacement Therapy (CRRT), and is projected to reach US$422.4 Million by 2026. China is expected to spearhead growth and emerge as the fastest growing regional market with a CAGR of 8.3% over the analysis period.
- The global Continuous Renal Replacement Therapy (CRRT) market is expected to increase rapidly in future, driven by rising incidence of acute kidney injury (AKI). AKI constitutes for about 60% mortality rate. CRRT is the most widely used treatment for AKI. The technique is the most preferred modality for treating and managing hemodynamically unstable patients with AKI. Benefits of CRRT include hemodynamic tolerance due to solute removal and slower ultrafiltration. Rise in ageing population, increase in ICU-related admissions, and higher acceptance of CRRT procedures due to clinical advantages over the intermittent blood purification methods are the other key factors driving market growth. As Renal replacement therapy (RRT) is required in patients with severe acute kidney injury (AKI), the rise in incidence of Acute Kidney Injury remains a major factor driving growth in the CRRT market. Renal disorders and kidney related ailments are also common among aged people, and spike in population of aged people inflates the potential patient population for CRRT treatments. Europe and the United States dominate the Continuous Renal Replacement Therapy market, driven by the fast growing aging population and increasing acute kidney injury cases. Growth in Asia-Pacific region is attributable to increasing aging population, rising cases of acute kidney injury/diseases, increasing healthcare expenditure, technological advancements, and governments` push for investments in the healthcare sector. The market for Continuous Venovenous Hemodiafiltration (CVVHDF) is forecast to grow at the fastest rate among all modalities over the analysis period. CVVHDF treatment modality leads to comprehensive removal and replacement of fluids and blood in the blood. The modality combines the principles of convection and diffusion, hemodialysis and hemofiltration, by using an efficient hemodiafilter. Given the modality`s ability to eliminate solute as well as fluid, the CVVHDF segment is poised to grow at a strong pace in the coming years. CVVHDF is a modality that is generally preferred among hospitals equipped with well-established intensive care units.
Select Competitors (Total 18 Featured)
Asahi Kasei Medical Co., Ltd.
B. Braun Melsungen AG
Baxter International, Inc.
Bellco Societa Unipersonale a r.l
Chongqing Shanwaishan Science and Technology Co., Ltd.
Fresenius Medical Care AG & Co. KgaA
Infomed SA
Medica SpA
Medical Components, Inc.
Medites Pharma Spol. S.R.O.
Medtronic PLC
Nikkiso Co., Ltd.
Ningbo Tianyi Medical Appliance Co., Ltd
NxStage Medical, Inc.
Toray Medical Co., Ltd.
Read the full report: https://www.reportlinker.com/p05798256/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Continuous Renal Replacement Therapy Market Set for a Steady
Growth
Dialysates & Replacement Fluids Dominate the Market,
Disposables to Register the Fastest Growth
Continuous Venovenous Hemofiltration (CVVH) Leads the Market,
CVVHDF to Exhibit the Fastest Growth
Europe and US Hold the Largest Share, China to Witness Fastest
Growth
Continuous Renal Replacement Therapy (CRRT) - Global Key
Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Future Endeavors in CRRT
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increase in Incidence of Acute Kidney Injury to Drive Market
Growth
Rise in Aging Population, Growing Number of ICU Patients Spurs
the Need for CRRT
Global Population Statistics for the 60+ Age Group by Region:
(in Thousands): 2017
Rising Incidence of Diabetes: A Key Risk Factor for Acute
Kidney Failure
Table 11: Worldwide Prevalence of Diabetes: Number of Adults:
(20-79) with Diabetes (in Millions) by Region for 2017 and 2045
Increasing Incidence of Cardiovascular Disease Drive Market Growth
Prevalence of Heart Failure in Select Countries
Advancements in CRRT Machines: Designed for Reliable and Safe
Treatment
Technological Advancements to Bolster Market Growth
Development of CRRT System for Pediatric Patients
Miniaturization and Wearable Technology Forays into Acute Renal
Replacement Domain
Reimbursement Scenario
Development of New Hemofilters to Propel Market Expansion
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Continuous Renal Replacement Therapy (CRRT) by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Continuous Renal Replacement
Therapy (CRRT) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 3: World 15-Year Perspective for Continuous Renal
Replacement Therapy (CRRT) by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets for Years 2012, 2021 &
2027
Table 4: World Recent Past, Current & Future Analysis for
Dialysates & Replacement Fluids by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 5: World Historic Review for Dialysates & Replacement
Fluids by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 6: World 15-Year Perspective for Dialysates & Replacement
Fluids by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2021 & 2027
Table 7: World Recent Past, Current & Future Analysis for
Disposables & Systems by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 8: World Historic Review for Disposables & Systems by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 9: World 15-Year Perspective for Disposables & Systems by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027
Table 10: World Recent Past, Current & Future Analysis for
Continuous Venovenous Hemofiltration by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 11: World Historic Review for Continuous Venovenous
Hemofiltration by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 12: World 15-Year Perspective for Continuous Venovenous
Hemofiltration by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2021 & 2027
Table 13: World Recent Past, Current & Future Analysis for
Continuous Venovenous Hemodialysis by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 14: World Historic Review for Continuous Venovenous
Hemodialysis by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 15: World 15-Year Perspective for Continuous Venovenous
Hemodialysis by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2021 & 2027
Table 16: World Recent Past, Current & Future Analysis for
Continuous Venovenous Hemodiafiltration by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 17: World Historic Review for Continuous Venovenous
Hemodiafiltration by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 18: World 15-Year Perspective for Continuous Venovenous
Hemodiafiltration by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
Table 19: World Recent Past, Current & Future Analysis for Slow
Continuous Filtration by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 20: World Historic Review for Slow Continuous Filtration
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 21: World 15-Year Perspective for Slow Continuous
Filtration by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
Continuous Renal Replacement Therapy (CRRT) Market Presence -
Strong/Active/Niche/Trivial - Key Competitors in the United
States for 2022 (E)
Table 22: USA Recent Past, Current & Future Analysis for
Continuous Renal Replacement Therapy (CRRT) by Product -
Dialysates & Replacement Fluids and Disposables & Systems -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 23: USA Historic Review for Continuous Renal Replacement
Therapy (CRRT) by Product - Dialysates & Replacement Fluids and
Disposables & Systems Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 24: USA 15-Year Perspective for Continuous Renal
Replacement Therapy (CRRT) by Product - Percentage Breakdown of
Value Sales for Dialysates & Replacement Fluids and Disposables &
Systems for the Years 2012, 2021 & 2027
Table 25: USA Recent Past, Current & Future Analysis for
Continuous Renal Replacement Therapy (CRRT) by Modality -
Continuous Venovenous Hemofiltration, Continuous Venovenous
Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow
Continuous Filtration - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 26: USA Historic Review for Continuous Renal Replacement
Therapy (CRRT) by Modality - Continuous Venovenous
Hemofiltration, Continuous Venovenous Hemodialysis, Continuous
Venovenous Hemodiafiltration and Slow Continuous Filtration
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 27: USA 15-Year Perspective for Continuous Renal
Replacement Therapy (CRRT) by Modality - Percentage Breakdown
of Value Sales for Continuous Venovenous Hemofiltration,
Continuous Venovenous Hemodialysis, Continuous Venovenous
Hemodiafiltration and Slow Continuous Filtration for the Years
2012, 2021 & 2027
CANADA
Table 28: Canada Recent Past, Current & Future Analysis for
Continuous Renal Replacement Therapy (CRRT) by Product -
Dialysates & Replacement Fluids and Disposables & Systems -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 29: Canada Historic Review for Continuous Renal
Replacement Therapy (CRRT) by Product - Dialysates &
Replacement Fluids and Disposables & Systems Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 30: Canada 15-Year Perspective for Continuous Renal
Replacement Therapy (CRRT) by Product - Percentage Breakdown of
Value Sales for Dialysates & Replacement Fluids and Disposables &
Systems for the Years 2012, 2021 & 2027
Table 31: Canada Recent Past, Current & Future Analysis for
Continuous Renal Replacement Therapy (CRRT) by Modality -
Continuous Venovenous Hemofiltration, Continuous Venovenous
Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow
Continuous Filtration - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 32: Canada Historic Review for Continuous Renal
Replacement Therapy (CRRT) by Modality - Continuous Venovenous
Hemofiltration, Continuous Venovenous Hemodialysis, Continuous
Venovenous Hemodiafiltration and Slow Continuous Filtration
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 33: Canada 15-Year Perspective for Continuous Renal
Replacement Therapy (CRRT) by Modality - Percentage Breakdown
of Value Sales for Continuous Venovenous Hemofiltration,
Continuous Venovenous Hemodialysis, Continuous Venovenous
Hemodiafiltration and Slow Continuous Filtration for the Years
2012, 2021 & 2027
JAPAN
Continuous Renal Replacement Therapy (CRRT) Market Presence -
Strong/Active/Niche/Trivial - Key Competitors in Japan for
2022 (E)
Table 34: Japan Recent Past, Current & Future Analysis for
Continuous Renal Replacement Therapy (CRRT) by Product -
Dialysates & Replacement Fluids and Disposables & Systems -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 35: Japan Historic Review for Continuous Renal
Replacement Therapy (CRRT) by Product - Dialysates &
Replacement Fluids and Disposables & Systems Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 36: Japan 15-Year Perspective for Continuous Renal
Replacement Therapy (CRRT) by Product - Percentage Breakdown of
Value Sales for Dialysates & Replacement Fluids and Disposables &
Systems for the Years 2012, 2021 & 2027
Table 37: Japan Recent Past, Current & Future Analysis for
Continuous Renal Replacement Therapy (CRRT) by Modality -
Continuous Venovenous Hemofiltration, Continuous Venovenous
Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow
Continuous Filtration - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 38: Japan Historic Review for Continuous Renal
Replacement Therapy (CRRT) by Modality - Continuous Venovenous
Hemofiltration, Continuous Venovenous Hemodialysis, Continuous
Venovenous Hemodiafiltration and Slow Continuous Filtration
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 39: Japan 15-Year Perspective for Continuous Renal
Replacement Therapy (CRRT) by Modality - Percentage Breakdown
of Value Sales for Continuous Venovenous Hemofiltration,
Continuous Venovenous Hemodialysis, Continuous Venovenous
Hemodiafiltration and Slow Continuous Filtration for the Years
2012, 2021 & 2027
CHINA
Continuous Renal Replacement Therapy (CRRT) Market Presence -
Strong/Active/Niche/Trivial - Key Competitors in China for
2022 (E)
Table 40: China Recent Past, Current & Future Analysis for
Continuous Renal Replacement Therapy (CRRT) by Product -
Dialysates & Replacement Fluids and Disposables & Systems -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 41: China Historic Review for Continuous Renal
Replacement Therapy (CRRT) by Product - Dialysates &
Replacement Fluids and Disposables & Systems Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 42: China 15-Year Perspective for Continuous Renal
Replacement Therapy (CRRT) by Product - Percentage Breakdown of
Value Sales for Dialysates & Replacement Fluids and Disposables &
Systems for the Years 2012, 2021 & 2027
Table 43: China Recent Past, Current & Future Analysis for
Continuous Renal Replacement Therapy (CRRT) by Modality -
Continuous Venovenous Hemofiltration, Continuous Venovenous
Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow
Continuous Filtration - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 44: China Historic Review for Continuous Renal
Replacement Therapy (CRRT) by Modality - Continuous Venovenous
Hemofiltration, Continuous Venovenous Hemodialysis, Continuous
Venovenous Hemodiafiltration and Slow Continuous Filtration
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 45: China 15-Year Perspective for Continuous Renal
Replacement Therapy (CRRT) by Modality - Percentage Breakdown
of Value Sales for Continuous Venovenous Hemofiltration,
Continuous Venovenous Hemodialysis, Continuous Venovenous
Hemodiafiltration and Slow Continuous Filtration for the Years
2012, 2021 & 2027
EUROPE
Continuous Renal Replacement Therapy (CRRT) Market Presence -
Strong/Active/Niche/Trivial - Key Competitors in Europe for
2022 (E)
Table 46: Europe Recent Past, Current & Future Analysis for
Continuous Renal Replacement Therapy (CRRT) by Geographic
Region - France, Germany, Italy, UK and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2020 through 2027 and % CAGR
Table 47: Europe Historic Review for Continuous Renal
Replacement Therapy (CRRT) by Geographic Region - France,
Germany, Italy, UK and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 48: Europe 15-Year Perspective for Continuous Renal
Replacement Therapy (CRRT) by Geographic Region - Percentage
Breakdown of Value Sales for France, Germany, Italy, UK and
Rest of Europe Markets for Years 2012, 2021 & 2027
Table 49: Europe Recent Past, Current & Future Analysis for
Continuous Renal Replacement Therapy (CRRT) by Product -
Dialysates & Replacement Fluids and Disposables & Systems -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 50: Europe Historic Review for Continuous Renal
Replacement Therapy (CRRT) by Product - Dialysates &
Replacement Fluids and Disposables & Systems Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 51: Europe 15-Year Perspective for Continuous Renal
Replacement Therapy (CRRT) by Product - Percentage Breakdown of
Value Sales for Dialysates & Replacement Fluids and Disposables &
Systems for the Years 2012, 2021 & 2027
Table 52: Europe Recent Past, Current & Future Analysis for
Continuous Renal Replacement Therapy (CRRT) by Modality -
Continuous Venovenous Hemofiltration, Continuous Venovenous
Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow
Continuous Filtration - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 53: Europe Historic Review for Continuous Renal
Replacement Therapy (CRRT) by Modality - Continuous Venovenous
Hemofiltration, Continuous Venovenous Hemodialysis, Continuous
Venovenous Hemodiafiltration and Slow Continuous Filtration
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 54: Europe 15-Year Perspective for Continuous Renal
Replacement Therapy (CRRT) by Modality - Percentage Breakdown
of Value Sales for Continuous Venovenous Hemofiltration,
Continuous Venovenous Hemodialysis, Continuous Venovenous
Hemodiafiltration and Slow Continuous Filtration for the Years
2012, 2021 & 2027
FRANCE
Continuous Renal Replacement Therapy (CRRT) Market Presence -
Strong/Active/Niche/Trivial - Key Competitors in France for
2022 (E)
Table 55: France Recent Past, Current & Future Analysis for
Continuous Renal Replacement Therapy (CRRT) by Product -
Dialysates & Replacement Fluids and Disposables & Systems -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 56: France Historic Review for Continuous Renal
Replacement Therapy (CRRT) by Product - Dialysates &
Replacement Fluids and Disposables & Systems Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 57: France 15-Year Perspective for Continuous Renal
Replacement Therapy (CRRT) by Product - Percentage Breakdown of
Value Sales for Dialysates & Replacement Fluids and Disposables &
Systems for the Years 2012, 2021 & 2027
Table 58: France Recent Past, Current & Future Analysis for
Continuous Renal Replacement Therapy (CRRT) by Modality -
Continuous Venovenous Hemofiltration, Continuous Venovenous
Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow
Continuous Filtration - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 59: France Historic Review for Continuous Renal
Replacement Therapy (CRRT) by Modality - Continuous Venovenous
Hemofiltration, Continuous Venovenous Hemodialysis, Continuous
Venovenous Hemodiafiltration and Slow Continuous Filtration
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 60: France 15-Year Perspective for Continuous Renal
Replacement Therapy (CRRT) by Modality - Percentage Breakdown
of Value Sales for Continuous Venovenous Hemofiltration,
Continuous Venovenous Hemodialysis, Continuous Venovenous
Hemodiafiltration and Slow Continuous Filtration for the Years
2012, 2021 & 2027
GERMANY
Continuous Renal Replacement Therapy (CRRT) Market Presence -
Strong/Active/Niche/Trivial - Key Competitors in Germany for
2022 (E)
Table 61: Germany Recent Past, Current & Future Analysis for
Continuous Renal Replacement Therapy (CRRT) by Product -
Dialysates & Replacement Fluids and Disposables & Systems -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 62: Germany Historic Review for Continuous Renal
Replacement Therapy (CRRT) by Product - Dialysates &
Replacement Fluids and Disposables & Systems Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 63: Germany 15-Year Perspective for Continuous Renal
Replacement Therapy (CRRT) by Product - Percentage Breakdown of
Value Sales for Dialysates & Replacement Fluids and Disposables &
Systems for the Years 2012, 2021 & 2027
Table 64: Germany Recent Past, Current & Future Analysis for
Continuous Renal Replacement Therapy (CRRT) by Modality -
Continuous Venovenous Hemofiltration, Continuous Venovenous
Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow
Continuous Filtration - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 65: Germany Historic Review for Continuous Renal
Replacement Therapy (CRRT) by Modality - Continuous Venovenous
Hemofiltration, Continuous Venovenous Hemodialysis, Continuous
Venovenous Hemodiafiltration and Slow Continuous Filtration
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 66: Germany 15-Year Perspective for Continuous Renal
Replacement Therapy (CRRT) by Modality - Percentage Breakdown
of Value Sales for Continuous Venovenous Hemofiltration,
Continuous Venovenous Hemodialysis, Continuous Venovenous
Hemodiafiltration and Slow Continuous Filtration for the Years
2012, 2021 & 2027
ITALY
Table 67: Italy Recent Past, Current & Future Analysis for
Continuous Renal Replacement Therapy (CRRT) by Product -
Dialysates & Replacement Fluids and Disposables & Systems -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 68: Italy Historic Review for Continuous Renal
Replacement Therapy (CRRT) by Product - Dialysates &
Replacement Fluids and Disposables & Systems Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 69: Italy 15-Year Perspective for Continuous Renal
Replacement Therapy (CRRT) by Product - Percentage Breakdown of
Value Sales for Dialysates & Replacement Fluids and Disposables &
Systems for the Years 2012, 2021 & 2027
Table 70: Italy Recent Past, Current & Future Analysis for
Continuous Renal Replacement Therapy (CRRT) by Modality -
Continuous Venovenous Hemofiltration, Continuous Venovenous
Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow
Continuous Filtration - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 71: Italy Historic Review for Continuous Renal
Replacement Therapy (CRRT) by Modality - Continuous Venovenous
Hemofiltration, Continuous Venovenous Hemodialysis, Continuous
Venovenous Hemodiafiltration and Slow Continuous Filtration
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 72: Italy 15-Year Perspective for Continuous Renal
Replacement Therapy (CRRT) by Modality - Percentage Breakdown
of Value Sales for Continuous Venovenous Hemofiltration,
Continuous Venovenous Hemodialysis, Continuous Venovenous
Hemodiafiltration and Slow Continuous Filtration for the Years
2012, 2021 & 2027
UNITED KINGDOM
Continuous Renal Replacement Therapy (CRRT) Market Presence -
Strong/Active/Niche/Trivial - Key Competitors in the United
Kingdom for 2022 (E)
Table 73: UK Recent Past, Current & Future Analysis for
Continuous Renal Replacement Therapy (CRRT) by Product -
Dialysates & Replacement Fluids and Disposables & Systems -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 74: UK Historic Review for Continuous Renal Replacement
Therapy (CRRT) by Product - Dialysates & Replacement Fluids and
Disposables & Systems Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 75: UK 15-Year Perspective for Continuous Renal
Replacement Therapy (CRRT) by Product - Percentage Breakdown of
Value Sales for Dialysates & Replacement Fluids and Disposables &
Systems for the Years 2012, 2021 & 2027
Table 76: UK Recent Past, Current & Future Analysis for
Continuous Renal Replacement Therapy (CRRT) by Modality -
Continuous Venovenous Hemofiltration, Continuous Venovenous
Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow
Continuous Filtration - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 77: UK Historic Review for Continuous Renal Replacement
Therapy (CRRT) by Modality - Continuous Venovenous
Hemofiltration, Continuous Venovenous Hemodialysis, Continuous
Venovenous Hemodiafiltration and Slow Continuous Filtration
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 78: UK 15-Year Perspective for Continuous Renal
Replacement Therapy (CRRT) by Modality - Percentage Breakdown
of Value Sales for Continuous Venovenous Hemofiltration,
Continuous Venovenous Hemodialysis, Continuous Venovenous
Hemodiafiltration and Slow Continuous Filtration for the Years
2012, 2021 & 2027
REST OF EUROPE
Table 79: Rest of Europe Recent Past, Current & Future Analysis
for Continuous Renal Replacement Therapy (CRRT) by Product -
Dialysates & Replacement Fluids and Disposables & Systems -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 80: Rest of Europe Historic Review for Continuous Renal
Replacement Therapy (CRRT) by Product - Dialysates &
Replacement Fluids and Disposables & Systems Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 81: Rest of Europe 15-Year Perspective for Continuous
Renal Replacement Therapy (CRRT) by Product - Percentage
Breakdown of Value Sales for Dialysates & Replacement Fluids
and Disposables & Systems for the Years 2012, 2021 & 2027
Table 82: Rest of Europe Recent Past, Current & Future Analysis
for Continuous Renal Replacement Therapy (CRRT) by Modality -
Continuous Venovenous Hemofiltration, Continuous Venovenous
Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow
Continuous Filtration - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 83: Rest of Europe Historic Review for Continuous Renal
Replacement Therapy (CRRT) by Modality - Continuous Venovenous
Hemofiltration, Continuous Venovenous Hemodialysis, Continuous
Venovenous Hemodiafiltration and Slow Continuous Filtration
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 84: Rest of Europe 15-Year Perspective for Continuous
Renal Replacement Therapy (CRRT) by Modality - Percentage
Breakdown of Value Sales for Continuous Venovenous
Hemofiltration, Continuous Venovenous Hemodialysis, Continuous
Venovenous Hemodiafiltration and Slow Continuous Filtration for
the Years 2012, 2021 & 2027
ASIA-PACIFIC
Continuous Renal Replacement Therapy (CRRT) Market Presence -
Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific
for 2022 (E)
Table 85: Asia-Pacific Recent Past, Current & Future Analysis
for Continuous Renal Replacement Therapy (CRRT) by Product -
Dialysates & Replacement Fluids and Disposables & Systems -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 86: Asia-Pacific Historic Review for Continuous Renal
Replacement Therapy (CRRT) by Product - Dialysates &
Replacement Fluids and Disposables & Systems Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 87: Asia-Pacific 15-Year Perspective for Continuous Renal
Replacement Therapy (CRRT) by Product - Percentage Breakdown of
Value Sales for Dialysates & Replacement Fluids and Disposables &
Systems for the Years 2012, 2021 & 2027
Table 88: Asia-Pacific Recent Past, Current & Future Analysis
for Continuous Renal Replacement Therapy (CRRT) by Modality -
Continuous Venovenous Hemofiltration, Continuous Venovenous
Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow
Continuous Filtration - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 89: Asia-Pacific Historic Review for Continuous Renal
Replacement Therapy (CRRT) by Modality - Continuous Venovenous
Hemofiltration, Continuous Venovenous Hemodialysis, Continuous
Venovenous Hemodiafiltration and Slow Continuous Filtration
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 90: Asia-Pacific 15-Year Perspective for Continuous Renal
Replacement Therapy (CRRT) by Modality - Percentage Breakdown
of Value Sales for Continuous Venovenous Hemofiltration,
Continuous Venovenous Hemodialysis, Continuous Venovenous
Hemodiafiltration and Slow Continuous Filtration for the Years
2012, 2021 & 2027
REST OF WORLD
Table 91: Rest of World Recent Past, Current & Future Analysis
for Continuous Renal Replacement Therapy (CRRT) by Product -
Dialysates & Replacement Fluids and Disposables & Systems -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 92: Rest of World Historic Review for Continuous Renal
Replacement Therapy (CRRT) by Product - Dialysates &
Replacement Fluids and Disposables & Systems Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 93: Rest of World 15-Year Perspective for Continuous
Renal Replacement Therapy (CRRT) by Product - Percentage
Breakdown of Value Sales for Dialysates & Replacement Fluids
and Disposables & Systems for the Years 2012, 2021 & 2027
Table 94: Rest of World Recent Past, Current & Future Analysis
for Continuous Renal Replacement Therapy (CRRT) by Modality -
Continuous Venovenous Hemofiltration, Continuous Venovenous
Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow
Continuous Filtration - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 95: Rest of World Historic Review for Continuous Renal
Replacement Therapy (CRRT) by Modality - Continuous Venovenous
Hemofiltration, Continuous Venovenous Hemodialysis, Continuous
Venovenous Hemodiafiltration and Slow Continuous Filtration
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 96: Rest of World 15-Year Perspective for Continuous
Renal Replacement Therapy (CRRT) by Modality - Percentage
Breakdown of Value Sales for Continuous Venovenous
Hemofiltration, Continuous Venovenous Hemodialysis, Continuous
Venovenous Hemodiafiltration and Slow Continuous Filtration for
the Years 2012, 2021 & 2027
IV. COMPETITION
Total Companies Profiled: 18
Read the full report: https://www.reportlinker.com/p05798256/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
